hit counter
BioMarin Pharmaceutical Inc. (BMRN) Stock News Sentiment & Price - Sentifly
BMRN - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



BioMarin Pharmaceutical Inc. (BMRN)

USA
Biotechnology
NASDAQ
BMRN Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
BMRN Latest news
Newsfile Corp
Neutral
BMRN LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving BioMarin Pharmaceutical Inc.
2021-11-11 20:49

New York, New York--(Newsfile Corp. - November 11, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased BioMarin Pharmaceutical Inc. ("BioMarin") (NASDAQ: BMRN) between January 13, 2020 and September 3, 2021.If you suffered a loss, contact us at the link below. There is no cost or obligation to you.https://www.wongesq.com/pslra-1/biomarin-pharmaceutical-inc-loss-submission-form-2?prid=21107&wire=5

Newsfile Corp
Neutral
BMRN Shareholder Alert: Rosen, Recognized Investor Counsel, Encourages BioMarin Pharmaceutical Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BMRN
2021-11-11 19:15

New York, New York--(Newsfile Corp. - November 11, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) between January 13, 2020 and September 3, 2021, inclusive (the "Class Period"), of the important December 22, 2021 lead plaintiff deadline.SO WHAT: If you purchased BioMarin securities during the Class Period you may be entitled to compensation without payment of any out of pocket...

Newsfile Corp
Neutral
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2021-11-11 15:07

Los Angeles, California--(Newsfile Corp. - November 11, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BioMarin Pharmaceutical Inc. ("BioMarin" or "the Company") (NASDAQ: BMRN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between January 13, 2020, and September 3, 2021, inclusive...

Newsfile Corp
Neutral
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of BioMarin Pharmaceutical Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2021 - BMRN
2021-11-11 12:58

New York, New York--(Newsfile Corp. - November 11, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of BioMarin Pharmaceutical Inc. ("BioMarin") (NASDAQ: BMRN) between January 13, 2020 and September 3, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. To get more information...

PRNewsWire
Neutral
BioMarin Pharmaceutical Inc. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against BioMarin Pharmac
2021-11-11 11:33

NEW YORK, Nov. 11, 2021 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP  announces that a federal securities class action lawsuit has been filed against BioMarin Pharmaceutical Inc. ("BioMarin" or the "Company") (NASDAQ: BMRN) in the United States District Court for the Northern District of California, on behalf of a class consisting of all persons and entities that purchased or otherwise acquired BioMarin securities between January 13, 2020 and September 3, 2021, both dates inclusive (the "Class Period"). All investors who purchased BioMarin Pharmaceutical Inc.   a nd incurred losses are u rged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.

Newsfile Corp
Neutral
BMRN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of December 22, 2021 in the Class Action Filed on Behalf of BioMarin Pharmaceutical Inc. Limited Shareholders
2021-11-10 22:38

New York, New York--(Newsfile Corp. - November 10, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) alleging that the Company violated federal securities laws.Class Period: January 13, 2020 and September 3, 2021Lead Plaintiff Deadline: December 22, 2021No obligation or cost to you.Learn more about your recoverable losses in BMRN:https://www.kleinstocklaw.com/pslra-1/biomarin-pharmaceutical-inc-loss-submission-form-2?id=21056&from=5

Business Wire
Neutral
BIOMARIN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against BioMarin Pharmaceuticals and Encourages Investors to Contact the Firm
2021-11-10 21:00

NEW YORK--(BUSINESS WIRE)-- #BioMarin--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against BioMarin Pharmaceuticals (“BioMarin” or the “Company”) (NASDAQ: BMRN) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired BioMarin securities between January 1, 2020 and September 3, 2021, both dates inclusive (the “Cla

Newsfile Corp
Neutral
BioMarin Shareholder Alert
2021-11-10 18:15

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In BioMarin To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - November 10, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BioMarin Pharmaceutical Inc. ("BioMarin" or the "Company") (NASDAQ: BMRN) and reminds investors of the December 22, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.If you suffered losses exceeding $50,000 investing in BioMarin stock or options between...

Newsfile Corp
Neutral
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioMarin Pharmaceutical Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2021 - (BMRN)
2021-11-10 16:40

New York, New York--(Newsfile Corp. - November 10, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN).Shareholders who purchased shares of BMRN during the class period listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/biomarin-pharmaceutical-inc-loss-submission-form-2/?id=21036&from=5

Newsfile Corp
Neutral
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2021-11-10 15:05

Los Angeles, California--(Newsfile Corp. - November 10, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against BioMarin Pharmaceutical Inc. ("BioMarin" or "the Company") (NASDAQ: BMRN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between January 13, 2020, and September 3, 2021, inclusive...

Loading more news...